Lianpan Dai

5.0k total citations · 2 hit papers
45 papers, 1.9k citations indexed

About

Lianpan Dai is a scholar working on Infectious Diseases, Immunology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Lianpan Dai has authored 45 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Infectious Diseases, 13 papers in Immunology and 12 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Lianpan Dai's work include SARS-CoV-2 and COVID-19 Research (22 papers), Mosquito-borne diseases and control (11 papers) and Viral Infections and Vectors (11 papers). Lianpan Dai is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (22 papers), Mosquito-borne diseases and control (11 papers) and Viral Infections and Vectors (11 papers). Lianpan Dai collaborates with scholars based in China, Czechia and United States. Lianpan Dai's co-authors include George F. Gao, Jinghua Yan, Yi Shi, Jianxun Qi, Hao Song, Kun Xu, Haixia Xiao, Jian Song, Xishan Lu and Yuan Yuan and has published in prestigious journals such as Advanced Materials, ACS Nano and Nature reviews. Immunology.

In The Last Decade

Lianpan Dai

42 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Viral targets for vaccines against COVID-19

2020 721 citations Lianpan Dai, George F. Gao Nature reviews. Immunology profile →
Structures of the Zika Virus Envelope Protein and Its Complex with a Flavivirus Broadly Protective Antibody

2016 379 citations Lianpan Dai, Jian Song et al. profile →

Peers

Lianpan Dai

PHEOH

EPIDE

IMMUN

Ramesh Jadi United States

Kanakatte Raviprakash United States

Kobporn Boonnak Thailand

Jing Zou United States

Astrid Borkowski Switzerland

Heidi Wood Canada

Mary E. Enama United States

Yiu‐Wing Kam Singapore

Kevin K. Ariën Belgium

Casey Johnson United States

Ramesh Jadi United States

Lianpan Dai

3.5k ×2.6

1.2k ×2.0

PHEOH

627 ×1.3

784 ×2.0

EPIDE

706 ×1.9

IMMUN

Citations per year, relative to Lianpan Dai Lianpan Dai (= 1×) peers Ramesh Jadi

Countries citing papers authored by Lianpan Dai

Since Specialization

Citations

This map shows the geographic impact of Lianpan Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lianpan Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lianpan Dai more than expected).

Fields of papers citing papers by Lianpan Dai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lianpan Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lianpan Dai. The network helps show where Lianpan Dai may publish in the future.

Co-authorship network of co-authors of Lianpan Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Lianpan Dai. A scholar is included among the top collaborators of Lianpan Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lianpan Dai. Lianpan Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Guo, Mengyu, Jiufeng Sun, Jie Mei, et al.. (2025). Pulmonary Surfactant Protein-Hitchhiking Inhalable Vaccines Augment Mucosal and Systemic Antiviral Immunity. ACS Nano. 19(43). 37895–37909.

Zhang, Rong, Dedong Li, Pengyue Gao, et al.. (2025). A SARS‐CoV and SARS‐CoV‐2 RBD Heterodimer Vaccine Candidate. Journal of Medical Virology. 97(5). e70367–e70367.

Xu, Kun, Yaling An, Haitang Xie, et al.. (2024). Neutralization of SARS-CoV-2 KP.1, KP.1.1, KP.2 and KP.3 by human and murine sera. npj Vaccines. 9(1). 215–215. 8 indexed citations

Fu, Wenjiao, Mengyu Guo, Zhenzhen Wang, et al.. (2024). Injectable Hydrogel Mucosal Vaccine Elicits Protective Immunity against Respiratory Viruses. ACS Nano. 18(17). 11200–11216. 24 indexed citations

Gao, Lidong, Peng He, Shilong Yang, et al.. (2024). Safety and immunogenicity of COVID-19 vaccine ZF2001 in Chinese aged 60 years and older. 2(5). 257–261. 1 indexed citations

An, Yaling, Gan Zhao, Ning Zhang, et al.. (2023). Robust and protective immune responses induced by heterologous prime‐boost vaccination with DNA‐protein dimeric RBD vaccines for COVID‐19. Journal of Medical Virology. 95(7). e28948–e28948. 1 indexed citations

Zheng, Yuxuan, Zhengrong Gao, Sheng Liu, et al.. (2023). Dosing interval regimen shapes potency and breadth of antibody repertoire after vaccination of SARS-CoV-2 RBD protein subunit vaccine. Cell Discovery. 9(1). 79–79. 5 indexed citations

An, Yaling, Patrice Dubois, Yan Huang, et al.. (2023). Effect of adjuvanting RBD-dimer-based subunit COVID-19 vaccines with Sepivac SWE™. Vaccine. 41(17). 2793–2803. 4 indexed citations

Zhang, Yanfang, Sheng Liu, Pu Han, et al.. (2023). Broad protective RBD heterotrimer vaccines neutralize SARS-CoV-2 including Omicron sub-variants XBB/BQ.1.1/BF.7. PLoS Pathogens. 19(9). e1011659–e1011659. 7 indexed citations

10.

She, Guangbiao, Wan‐Qiang Lv, Jing Liu, et al.. (2023). Developmental and reproductive toxicity of a recombinant protein subunit COVID-19 vaccine (ZF2001) in rats. npj Vaccines. 8(1). 74–74. 3 indexed citations

11.

Zhao, Min, Fei Shao, Zhen Liu, et al.. (2023). Spatially resolved transcriptomics reveals distinct pulmonary immune responses during influenza virus and SARS-CoV-2 infections. Science Bulletin. 68(24). 3137–3141. 5 indexed citations

12.

Xu, Kun, et al.. (2022). Immunogenicity, efficacy and safety of COVID-19 vaccines: an update of data published by 31 December 2021. International Immunology. 34(12). 595–607. 22 indexed citations

13.

Jin, Pengfei, Xiling Guo, Wei Chen, et al.. (2022). Safety and immunogenicity of heterologous boost immunization with an adenovirus type-5-vectored and protein-subunit-based COVID-19 vaccine (Convidecia/ZF2001): A randomized, observer-blinded, placebo-controlled trial. PLoS Medicine. 19(5). e1003953–e1003953. 23 indexed citations

14.

Liu, Jiaojiao, Kun Xu, Man Xing, et al.. (2021). Heterologous prime-boost immunizations with chimpanzee adenoviral vectors elicit potent and protective immunity against SARS-CoV-2 infection. Cell Discovery. 7(1). 123–123. 21 indexed citations

15.

Bào, Yīmíng, Yuqing Zhang, Guanglin Lei, et al.. (2021). Integrated gut virome and bacteriome dynamics in COVID-19 patients. Gut Microbes. 13(1). 1–21. 95 indexed citations

16.

Dai, Lianpan, Kun Xu, Jinhe Li, et al.. (2021). Protective Zika vaccines engineered to eliminate enhancement of dengue infection via immunodominance switch. Nature Immunology. 22(8). 958–968. 30 indexed citations

17.

Dai, Lianpan & George F. Gao. (2020). Viral targets for vaccines against COVID-19. Nature reviews. Immunology. 21(2). 73–82. 721 indexed citations breakdown →

18.

Lu, Xishan, Haixia Xiao, Shihua Li, et al.. (2019). Double Lock of a Human Neutralizing and Protective Monoclonal Antibody Targeting the Yellow Fever Virus Envelope. Cell Reports. 26(2). 438–446.e5. 37 indexed citations

19.

Shi, Yi, Lianpan Dai, Hao Song, & George F. Gao. (2018). Structures of Zika Virus E & NS1: Relations with Virus Infection and Host Immune Responses. Advances in experimental medicine and biology. 1062. 77–87. 18 indexed citations

20.

Dai, Peihong, Weiyi Wang, Hua Cao, et al.. (2014). Modified Vaccinia Virus Ankara Triggers Type I IFN Production in Murine Conventional Dendritic Cells via a cGAS/STING-Mediated Cytosolic DNA-Sensing Pathway. PLoS Pathogens. 10(4). e1003989–e1003989. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact